Reporting Of Randomized Controlled Hodgkin Lymphoma Trials Found Unsatisfactory
Thilo Kober, Ph.D., of the Cochrane Haematological Malignancies Group in Cologne, Germany, and colleagues analysed 242 published reports of randomized controlled trials in Hodgkin lymphoma patients published from 1996 to 2002. Reports were grouped into two pre-CONSORT time periods (1966-1988 and 1989-1995), and one post-CONSORT time period (1996-2002).
In all three time periods, 75% or more of the studies only addressed 6 of the 14 criteria based on the CONSORT statement. Items necessary to evaluate the quality of the methods used by researchers were reported in fewer than 20% of the studies. The authors consider the overall level of reporting in randomized controlled trials on Hodgkin lymphoma unsatisfactory.
The authors write, "The CONSORT Statement and checklist is one major initiative to facilitate clear reporting and to provide more transparency in the way in which research results are conveyed in biomedical journals. Thus, our findings strongly support making use of the CONSORT checklist mandatory for all authors reporting on [randomized controlled trials]."
----------------------------
Article adapted by Start Sanatate from original press release.
----------------------------
Contact: Thilo Kober, tk_smilingpressproductions@yahoo.com
The Journal of the National Cancer Institute is published by Oxford University Press and is not affiliated with the National Cancer Institute. Attribution to the Journal of the National Cancer Institute is requested in all news coverage. Visit the Journal online at http://jncicancerspectrum.oxfordjournals.org/.
Contact: Ariel Whitworth
Journal of the National Cancer Institute
Raportarea randomizate controlate Hodgkin Lymphoma Procesele gãsite nesatisfãcãtoare - Reporting Of Randomized Controlled Hodgkin Lymphoma Trials Found Unsatisfactory - articole medicale engleza - startsanatate